Using SMD alone to screen older patients for geriatric assessment requires improvement. High-sensitivity cut-off points could miss 11-24% of patients with frailty, and many non-frail patients may be flagged. Screening with SMD is practical but work is needed to understand clinical andresource impacts of different cut-off points. Future research should evaluate performance with additional clinical data and in subgroups.
Keyphrases
- skeletal muscle
- community dwelling
- type diabetes
- healthcare
- newly diagnosed
- ejection fraction
- cardiovascular disease
- palliative care
- papillary thyroid
- prognostic factors
- squamous cell carcinoma
- machine learning
- electronic health record
- big data
- metabolic syndrome
- glycemic control
- young adults
- artificial intelligence
- weight loss
- lymph node metastasis